Limited detection of small (≤ 10 mm) colorectal liver metastasis at preoperative CT in patients undergoing liver resection

Objective To retrospectively determine the sensitivity of preoperative CT in the detection of small (≤ 10 mm) colorectal liver metastasis (CRLM) nodules in patients undergoing liver resection. Methods The institutional review board approved the study and waived informed consent. We included 461 pathologically confirmed CRLM nodules in 211 patients (including 71 women; mean age, 66.4 years) who underwent 229 liver resections following abdominal CT. Prior to 163 resections, gadoxetic acid-enhanced liver MR imaging was also performed. Nodules were matched between pathology reports and prospective CT reports following a predefined algorithm. Per-nodule sensitivity of CT was calculated by nodule-size category. Generalized estimating equations were used to adjust for within-case correlation. Results Fourteen nodule sizes were missing in the pathology report. Nodules of 1–5 mm and 6–10 mm accounted for 8.1% (n = 36) and 23.5% (n = 105) of the remaining 447 nodules, and the number of nodules gradually decreased as nodule size increased beyond 10 mm. The overall sensitivity of CT was 81.2% (95% confidence interval, 77.1%, 85.2%; 365/461). The sensitivity was 8% (0%, 17%; 3/36), 55% (45%, 65%; 59/105), 91%, 95%, and 100% for nodules of 1–5 mm, 6–10 mm, 11–15 mm, 16–20 mm, and >20 mm, respectively. The nodule-size distribution was similar between resections undergoing gadoxetic acid-enhanced MR imaging and those not undergoing the MR imaging. Conclusion CT has limited sensitivity for nodules of ≤ 10 mm and particularly of ≤ 5 mm.

[1]  Christophe Aubé,et al.  A meta-analysis of diffusion-weighted and gadoxetic acid-enhanced MR imaging for the detection of liver metastases , 2016, European Radiology.

[2]  Jeong Min Lee,et al.  ESGAR consensus statement on liver MR imaging and clinical use of liver-specific contrast agents , 2015, European Radiology.

[3]  E. Merkle,et al.  Consensus report from the 7th International Forum for Liver Magnetic Resonance Imaging , 2015, European Radiology.

[4]  J. Byun,et al.  Evaluation of early-stage hepatocellular carcinoma by magnetic resonance imaging with gadoxetic acid detects additional lesions and increases overall survival. , 2015, Gastroenterology.

[5]  Robert M. Marks,et al.  Diagnostic Accuracy of Preoperative Gadoxetic Acid-enhanced 3-T MR Imaging for Malignant Liver Lesions by Using Ex Vivo MR Imaging-matched Pathologic Findings as the Reference Standard. , 2015, Radiology.

[6]  S. Park,et al.  Incremental value of liver MR imaging in patients with potentially curable colorectal hepatic metastasis detected at CT: a prospective comparison of diffusion-weighted imaging, gadoxetic acid-enhanced MR imaging, and a combination of both MR techniques. , 2015, Radiology.

[7]  Caroline Reinhold,et al.  Consensus statements from a multidisciplinary expert panel on the utilization and application of a liver-specific MRI contrast agent (gadoxetic acid). , 2015, AJR. American journal of roentgenology.

[8]  Yoo-Seok Yoon,et al.  Role of Gadoxetic Acid-Enhanced Magnetic Resonance Imaging in the Preoperative Evaluation of Small Hepatic Lesions in Patients with Colorectal Cancer , 2015, World Journal of Surgery.

[9]  A. Ba-Ssalamah,et al.  Preoperative evaluation of colorectal liver metastases: comparison between gadoxetic acid-enhanced 3.0-T MRI and contrast-enhanced MDCT with histopathological correlation , 2013, European Radiology.

[10]  K. Awai,et al.  Detectability of hepatocellular carcinoma by gadoxetate disodium‐enhanced hepatic MRI: Tumor‐by‐tumor analysis in explant livers , 2013, Journal of magnetic resonance imaging : JMRI.

[11]  E. Merkle,et al.  Hepatocellular carcinoma in a North American population: Does hepatobiliary MR imaging with Gd‐EOB‐DTPA improve sensitivity and confidence for diagnosis? , 2013, Journal of magnetic resonance imaging : JMRI.

[12]  Theo Stijnen,et al.  Methods for calculating sensitivity and specificity of clustered data: a tutorial. , 2012, Radiology.

[13]  Myeong-Jin Kim,et al.  Detection of liver metastases using gadoxetic‐enhanced dynamic and 10‐ and 20‐minute delayed phase MR imaging , 2012, Journal of magnetic resonance imaging : JMRI.

[14]  J. Stoker,et al.  Diagnostic imaging of colorectal liver metastases with CT, MR imaging, FDG PET, and/or FDG PET/CT: a meta-analysis of prospective studies including patients who have not previously undergone treatment. , 2010, Radiology.

[15]  Myeong-Jin Kim,et al.  Added value of gadoxetic acid-enhanced hepatobiliary phase MR imaging in the diagnosis of hepatocellular carcinoma. , 2010, Radiology.

[16]  E. Baudin,et al.  Hepatic Metastases From Neuroendocrine Tumors With a “Thin Slice” Pathological Examination: They are Many More Than You Think … , 2010, Annals of surgery.

[17]  V. Torri,et al.  Performance of imaging modalities in diagnosis of liver metastases from colorectal cancer: A systematic review and meta‐analysis , 2010, Journal of magnetic resonance imaging : JMRI.

[18]  D. Sargent,et al.  Improved survival in metastatic colorectal cancer is associated with adoption of hepatic resection and improved chemotherapy. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[19]  T. Gruenberger,et al.  Adequate preoperative staging rarely leads to a change of intraoperative strategy in patients undergoing surgery for colorectal cancer liver metastases. , 2008, Surgery.

[20]  M. Kadoya,et al.  Detection of Hepatic Metastases From Colorectal Carcinoma: Comparison of Histopathologic Features of Anatomically Resected Liver With Results of Preoperative Imaging , 2007, Journal of clinical gastroenterology.

[21]  I. Floriani,et al.  Diagnostic accuracy of portal-phase CT and MRI with mangafodipir trisodium in detecting liver metastases from colorectal carcinoma. , 2007, Clinical radiology.

[22]  E. Leen,et al.  Radiological staging of colorectal liver metastases. , 2007, Surgical oncology.

[23]  A. Zwinderman,et al.  Colorectal liver metastases: CT, MR imaging, and PET for diagnosis--meta-analysis. , 2005, Radiology.

[24]  Evelyne M. Loyer,et al.  Effect of Surgical Margin Status on Survival and Site of Recurrence After Hepatic Resection for Colorectal Metastases , 2005, Annals of surgery.

[25]  P. Clavien,et al.  Does the Novel PET/CT Imaging Modality Impact on the Treatment of Patients With Metastatic Colorectal Cancer of the Liver? , 2004, Annals of surgery.

[26]  R. Hoda,et al.  Rosai and Ackerman???s Surgical Pathology , 2004 .

[27]  M. Haider,et al.  Multi-detector row helical CT in preoperative assessment of small (< or = 1.5 cm) liver metastases: is thinner collimation better? , 2002, Radiology.

[28]  P. Robinson,et al.  Hepatic lesion detection: comparison of MR imaging after the administration of superparamagnetic iron oxide with dual-phase CT by using alternative-free response receiver operating characteristic analysis. , 1999, Radiology.

[29]  J. Rosai Comprar Rosai and Ackerman's Surgical Pathology - 2 Volume Set, 10th Edition | Juan Rosai | 9780323069694 | Mosby , 2011 .

[30]  C. Bartolozzi,et al.  Detection of colorectal liver metastases: a prospective multicenter trial comparing unenhanced MRI, MnDPDP-enhanced MRI, and spiral CT , 2004, European Radiology.